Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains
Journal Article
·
· Nature Communications
more »
- Univ. of Massachusetts, Worcester, MA (United States). Chan Medical School
- New York Univ. (NYU), NY (United States). Grossman School of Medicine
- National Institutes of Health (NIH), Bethesda, MD (United States)
- SYL Consulting, Thousand Oak, CA (United States)
- Duke Univ., Durham, NC (United States)
- Harvard Medical School, Boston, MA (United States)
The vaccine elicitation of HIV tier-2-neutralization antibodies has been a challenge. Here, we report the isolation and characterization of a CD4-binding site (CD4bs) specific monoclonal antibody, HmAb64, from a human volunteer immunized with a polyvalent DNA prime-protein boost HIV vaccine. HmAb64 is derived from heavy chain variable germline gene IGHV1-18 and light chain germline gene IGKV1-39. It has a third heavy chain complementarity-determining region (CDR H3) of 15 amino acids. On a cross-clade panel of 208 HIV-1 pseudo-virus strains, HmAb64 neutralized 20 (10%), including tier-2 strains from clades B, BC, C, and G. The cryo-EM structure of the antigen-binding fragment of HmAb64 in complex with a CNE40 SOSIP trimer revealed details of its recognition; HmAb64 uses both heavy and light CDR3s to recognize the CD4-binding loop, a critical component of the CD4bs. This study demonstrates that a gp120-based vaccine can elicit antibodies capable of tier 2-HIV neutralization.
- Research Organization:
- Brookhaven National Laboratory (BNL), Upton, NY (United States). National Synchrotron Light Source II (NSLS-II)
- Sponsoring Organization:
- USDOE Office of Science (SC)
- Grant/Contract Number:
- SC0012704
- OSTI ID:
- 2470333
- Journal Information:
- Nature Communications, Journal Name: Nature Communications Journal Issue: 1 Vol. 15; ISSN 2041-1723
- Publisher:
- Nature Publishing GroupCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Fusion proteins of HIV-1 envelope glycoprotein gp120 with CD4-induced antibodies showed enhanced binding to CD4 and CD4 binding site antibodies
HIV-1 CD4-binding site germline antibody–Env structures inform vaccine design
Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120
Journal Article
·
Fri Sep 07 00:00:00 EDT 2012
· Biochemical and Biophysical Research Communications
·
OSTI ID:22210242
HIV-1 CD4-binding site germline antibody–Env structures inform vaccine design
Journal Article
·
Sun Oct 16 20:00:00 EDT 2022
· Nature Communications
·
OSTI ID:2423906
Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120
Journal Article
·
Tue Jan 12 23:00:00 EST 2010
· Science
·
OSTI ID:1006070